New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

Medical imaging scans that create detailed images of the body’s internal structures are widely used in medicine. Doctors need them to detect and manage certain types of cancer, assess the extent of ...

LOS ANGELES (KABC) -- New technology that's allowing doctors to pinpoint prostate cancer long before it becomes a threat is now widely available. A former firefighter mentioned how this new imaging ...

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

PLYMOUTH MEETING, PA — A study published in the February 2026 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that incorporating prostate-specific membrane antigen PET/CT ...